This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ABT-413
Description: ABT-412 targets sphingosine-1-phosphate receptor 1 (S1P1) and 5 (S1P5).
Additional information available to subscribers only: